CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy

By sjmartinez • April 1, 2025

Marshalek JP, Qing X, Tomassetti S. CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy. World J Oncol. 2025 Apr;16(2):235-238. doi: 10.14740/wjon2534. Epub 2025 Mar 13. PMID: 40162108; PMCID: PMC11954608.

Tags: Harbor UCLA, Hematology/Oncology, Publications

Mannan immunoassay for diagnosis of invasive mucormycosis: assay development, preclinical testing and evaluation in an animal model

Burnham-Marusich AR, Pandit V, Alkhazraji S, Gu Y, Zayac KR, Wingard JR, Culver EL, Walish JJ, Ibrahim AS, Kozel TR. Mannan immunoassay for diagnosis of[...]

Early-Onset Gastric Cancer as a High-Risk Disease Entity in the United States: Clinicopathologic Features, Regional Variation, and Outcomes

Castillo DR, Shah P, Tai D, Guo M, Hazeltine M, Guzman S, Park D, Mannan R, Xing Y, Brar G, Raoof M, Eng C, Wu[...]

Women and Herpes Zoster in the United States: Risk and Prevention Management-A Narrative Review

Campos R, Caldera F, Carrico J, Cochrane C, Eltoukhy N, Huang C, Kneller S, Rutland C, Slovis J. Women and Herpes Zoster in the United[...]